Proto Labs Beats Q2 Estimates, Raises Full-Year Revenue Growth Outlook to 8-10%
PRLB has more than doubled off its 52-week low of $38.62.
Summary
Proto Labs reported Q2 2026 revenue of $149.3M (+10.6% YoY) and non-GAAP EPS of $0.60, beating estimates. Full-year revenue growth guidance was raised to 8-10%.
Key Events · Earnings and Guidance · PRLB
-
Record Q2 Revenue, Beat Estimates
Revenue reached $149.3 million, a 10.6% increase year-over-year, exceeding expectations. Non-GAAP EPS of $0.60 compared to $0.41 in Q2 2025.
-
Full-Year Guidance Raised
Management lifted 2026 revenue growth guidance to 8-10% from the prior 6-8%, reflecting confidence in demand trends and strategic execution.
-
Margin Expansion Continues
Non-GAAP gross margin improved 200 bps to 46.8%, and non-GAAP operating margin expanded 340 bps to 12.0%, driven by higher revenue and operational leverage.
-
Q3 2026 Outlook Provided
The company expects Q3 revenue between $145 million and $153 million, with non-GAAP EPS of $0.56 to $0.64.
Analysis · PRLB · Manufacturing
Proto Labs delivered record quarterly revenue of $149.3 million, up 10.6% year-over-year, and raised its full-year 2026 revenue growth guidance from 6-8% to 8-10%. Non-GAAP earnings per share of $0.60 beat expectations, driven by expanding gross and operating margins. The company is seeing traction with larger strategic customers, and the raised guidance signals confidence in sustained momentum. With shares trading near a 52-week high, the results reinforce the bull case but also raise the bar for execution.
At the time of this filing, PRLB was trading at $79.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $38.62 to $83.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.